BARCLAYS PLC - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$11,000
-38.9%
1,457
-45.4%
0.00%
Q4 2016$18,000
-85.5%
2,669
-82.3%
0.00%
Q3 2016$124,000
-80.1%
15,106
-80.4%
0.00%
-100.0%
Q2 2016$623,000
+62200.0%
76,927
+25976.9%
0.00%
Q1 2016$1,000
-80.0%
295
-63.3%
0.00%
Q4 2015$5,000
+400.0%
804
+242.1%
0.00%
Q3 2015$1,000
-87.5%
235
-72.7%
0.00%
Q2 2015$8,0008610.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,232,416$26,183,00012.58%
Avoro Capital Advisors LLC 4,338,557$35,142,0007.81%
FRAZIER MANAGEMENT LLC 774,720$6,275,0005.00%
Broadfin Capital, LLC 3,170,759$25,683,0002.50%
Perceptive Advisors 3,611,976$29,257,0002.03%
Ghost Tree Capital, LLC 700,000$5,670,0001.64%
Opaleye Management Inc. 260,000$2,106,0001.41%
Rhenman & Partners Asset Management AB 650,000$5,265,0000.94%
QVT Financial LP 1,598,309$12,946,0000.89%
Cormorant Asset Management, LP 505,941$4,098,0000.58%
View complete list of LION BIOTECHNOLOGIES INC shareholders